STOCKHOLDERS’ EQUITY | NOTE 12 - STOCKHOLDERS’ EQUITY Capital Structure On March 28, 2014, in connection with the Reincorporation (see Note 1), all share and per share values for all periods presented in the accompanying consolidated financial statements are retroactively restated for the effect of the Reincorporation. On March 5, 2016, the Company shareholders voted in favor of an amendment to its Articles of Incorporation to increase the total number of shares of authorized capital stock to 800,000,000 750,000,000 50,000,000 220,000,000 200,000,000 20,000,000 Effective March 8, 2018, we conducted a reverse split of our common stock at a ratio of 1 for 150 On July 24, 2019, the Company filed a Certificate of Change (the “Certificate of Change”) with the Nevada Secretary of State. The Certificate of Change provides for (i) a 1-for-15 reverse split 0.0001 0.0001 750,000,000 50,000,000 50,000,000 3,333,333 On May 28, 2021, the Company effected a reverse stock split of its common stock at a ratio of 1-for-5 (the “Reverse Split”). No fractional shares of common stock were issued as a result of the Reverse Split. Stockholders of record who were otherwise entitled to receive a fractional share received a whole share. The conversion or exercise prices of Company’s issued and outstanding convertible securities, stock options and warrants will be adjusted accordingly. All information presented in this Annual Report on Form 10-K, assumes a 1-for-5 reverse stock split of Company’s outstanding shares of common stock, and unless otherwise indicated, all such amounts and corresponding conversion price or exercise price data set forth in this Annual Report on Form 10K have been adjusted to give effect to such assumed reverse stock split. Listing on the Nasdaq Capital Market Our common stock and warrants have been trading on the Nasdaq Capital Market under the symbols “NXPL” and “NXPLW,” respectively, since January 21, 2022. Prior to January 21, 2022, our common stock and warrants were traded on the Nasdaq Capital Market under the symbols “OSAT” and “OSATW,” respectively. The authorized capital of the Company consists of 50,000,000 shares of common stock, par value $ 0.0001 per share and 3,333,333 shares of preferred stock, par value $ 0.0001 per share. As of December 31, 2021, and 2020, there were and 7,053,146 and 817,450 shares of common stock and 0 shares of preferred stock issued and outstanding, respectively. Preferred Stock As of December 31, 2021 and 2020, there were no NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) Warrants As of December 31, 2021, there were 2,836,092 2,530,092 On June 2, 2021, the Company issued 2,880,000 2,880,000 5.00 5 On June 10, 2021, the Company issued 1,000 1,000 5.00 5,000 On June 28, 2021, the Company issued an additional 432,000 432,000 5.00 5 On July 6, 2021, the Company issued 78,500 78,500 5.00 392,500 On July 8, 2021, the Company issued 425,000 425,000 5.00 2,125,000 On July 12, 2021, the Company issued 2,000 2,000 5.00 10,000 On July 13, 2021, the Company issued 59,853 59,853 5.00 299,265 On July 14, 2021, the Company issued 278,555 278,555 5.00 1,392,775 On July 15, 2021, the Company issued 5,000 5,000 5,000 On July 19, 2021, the Company issued 1,000 1,000 5.00 5,000 On July 30, 2021, the Company issued 80,000 80,000 5.00 400,000 Underwriter Warrants In addition to, but separate from, the registered warrants included in the units sold in the June Offering, the Company issued 144,000 five 5.50 110 As of December 31, 2021, there were 144,000 Underwriter Warrants issued and outstanding. A summary of the status of the Company’s total outstanding warrants and changes during the year ended December 31, 2021 is as follows: SCHEDULE OF OUTSTANDING STOCK WARRANTS ACTIVITIES Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Balance at January 1, 2020 800 $ 300.00 2.37 Granted - - - Exercised - - - Forfeited - - - Cancelled - - - Balance outstanding and exercisable at December 31, 2020 800 $ 300.00 1.37 Balance at January 1, 2021 800 $ 300.00 1.37 Granted 3,456,000 - - Exercised (925,908 ) - - Forfeited - - - Cancelled (800 ) - - Balance outstanding and exercisable at December 31, 2021 2,530,092 $ 5.00 4.42 As of December 31, 2021, and December 31, 2020, there were 2,530,092 800 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) Common Stock For the year ended December 31, 2021 On January 12, 2021, the Company issued an aggregate of 30,000 30,000 1.00 On February 23, 2021, the Company issued an aggregate of 80,289 80,289 1.00 On February 23, 2021, the Company issued an aggregate of 120,000 150,000 1.25 On February 23, 2021, the Company issued an aggregate of 1,000 14,200 On March 1, 2021, the Company issued an aggregate of 149,532 149,532 1.00 On March 1, 2021, the Company issued an aggregate of 38,616 48,270 1.25 On March 24, 2021, the Company’s shareholders via majority shareholder consent authorized a stock split not to exceed 1 for 5 reverse stock split. A definitive Information Statement relating to the shareholder consent was filed with the SEC on March 13, 2021. The Company’s Board of Directors subsequently approved the 1-for-5 reverse stock split. The Company has filed a Certificate of Change to its Amended and Restated Articles of Incorporation to effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5. The effective time of the reverse stock split will be 12:01 a.m. ET on May 28, 2021 . The Company’s common stock will begin trading on a split-adjusted basis commencing upon market open on May 28, 2021. The common stock will be assigned a new CUSIP number, 68557F 209. The warrants will be assigned the CUSIP number, 68557F 118. No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders of record who would otherwise be entitled to receive a fractional share will receive a whole share. On May 20, 2021, Company issued an aggregate of 29,800 29,800 1.00 On May 27, 2021, Company issued an aggregate of 897,231 1,156,377 1.29 On May 28, 2021, Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with Maxim Group LLC(the “Underwriter”), pursuant to which the Company agreed to issue and sell to the Underwriter in an underwritten public offering 2,880,000 units consisting of one share of common stock and one warrant, exercisable for one share of common stock at a public offering price of $ 5.00 per unit, (after giving effect to a 1-for-5 reverse stock split, discussed above) for aggregate gross proceeds of approximately $ 14,400,000 before deducting underwriting discounts, commissions, and other offering expenses (the “June Offering”). The common stock and warrants were immediately separable and were issued separately. The common stock and warrants began trading on the Nasdaq Capital Market, on May 28, 2021, under the symbols “OSAT” and “OSATW,” respectively. In addition, the Company In addition, the Company has granted the Underwriter a 45-day option to purchase an additional 432,000 shares of common stock and/or warrants to purchase up to an aggregate of 432,000 shares of common stock, in any combination thereof, at the public offering price per security, less the underwriting discounts and commissions, to cover over-allotments, if any. The June Offering closed on June 2, 2021.In connection with closing of the June Offering, the Underwriter partially exercised its overallotment option and purchased an additional 432,000 warrants at $ 0.01 per warrant for additional gross proceeds to the Company of $ 4,320 . On June 28, 2021, the Underwriter, upon the exercise in full of the balance of its over-allotment option, purchased 432,000 additional 2,160,000 1,983,226 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) We have issued to the Underwriter warrants to purchase up to a total of 144,000 shares of common stock ( 5 5.50 per share, or 110 % of the public offering price per unit in the offering. The Underwriter Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(1) of FINRA. The underwriter (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for certain piggyback registration rights. The piggyback registration rights provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the Underwriter Warrants. The exercise price and number of shares issuable upon exercise of the Underwriter Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price. The June Offering of common stock and warrants, and the underwriter’s exercise of the over-allotment option in connection therewith, resulted in total gross proceeds of approximately $ 16,560,000 On June 10, 2021, the Company issued 1,000 1,000 5.00 5,000 On July 6, 2021, the Company issued 78,500 78,500 5.00 392,500 On July 8, 2021, the Company issued 425,000 425,000 5.00 2,125,000 On July 12, 2021, the Company issued 2,000 2,000 5.00 10,000 On July 13, 2021, the Company issued 59,853 59,853 5.00 299,265 On July 14, 2021, the Company issued 278,555 278,555 5.00 1,392,775 On July 15, 2021, the Company issued 5,000 5,000 5,000 On July 19, 2021, the Company issued 1,000 1,000 5.00 5,000 On July 30, 2021, the Company issued 80,000 80,000 5.00 400,000 On September 3, 2021, the Company issued 10,000 5.35 On September 14, 2021, the Company issued 40,000 5.35 On September 22, 2021, the Company issued a total of 12,437 common shares for the exercise of 14,200 options through a cashless exercise using 2,763 options for the $ 1.00 exercise price and in connection with a 1,000 restricted stock award. NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) On October 21, 2021, the Company issued 10,000 shares of common stock in connection with restricted stock awards, with a fair market value of $ 4.75 per share, from the date of the award, for stock-based compensation of $ 47,500 . On December 21, 2021, the Company issued 563,500 3.74 2,107,490 On December 28, 2021, the Company awarded at total of 15,000 restricted stock awards, at a fair market value of $ 3.81 , from the date of issuance. The Company issued 10,393 shares of common stock, withholding 4,607 of the award for the payment of taxes, this resulted in net stock-based compensation of $ 39,597 . For the year ended December 31, 2020 The Company issued a total of 791,760 On January 30, 2020, the Company issued an aggregate of 3,629 1,815 0.50 On January 31, 2020, the Company issued an aggregate of 3,629 1,815 0.50 On February 10, 2020, the Company issued an aggregate of 5,084 2,542 0.50 On February 11, 2020, the Company issued an aggregate of 4,716 2,358 0.50 On February 18, 2020, the Company issued an aggregate of 2,638 1,319 0.50 On February 19, 2020, the Company issued an aggregate of 894 446 0.50 On March 9, 2020, the Company issued an aggregate of 2,061 1,031 0.50 On April 17, 2020, the Company issued an aggregate of 1,409 705 0.50 On April 22, 2020, the Company issued an aggregate of 74 37 0.50 On June 22, 2020, the Company issued an aggregate of 2,687 2,687 1.00 On July 8, 2020, the Company issued an aggregate of 219 219 1.00 On July 16, 2020, the Company’s Board of Directors approved, and the Company entered into a 12-month consulting agreement (“Consulting Agreement”) with an unrelated third-party for capital raising advisory services and business growth and development services, with the term renewable upon mutual consent of the parties. Upon signing of the Consulting Agreement, the Company agreed to issue 4,000 restricted shares of its common stock to the consultant (the “Consulting Shares”), 1,000 additional restricted shares of common stock to be issued quarterly until the consultant may receive cash compensation for its services, which will be determined, upon completion of certain milestones, by the Company’s CEO. On July 22, 2020, the Company issued 4,000 common stock valued at $ 50,200 and on November 13, 2020, the Company issued 1,000 common stock valued at $ 11,250 . On July 23, 2020, the Company issued an aggregate of 468 468 1.00 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) On August 25, 2020, David Phipps exercised 80,000 22,000 minus * divided by 85,960 On August 25, 2020, the Company issued 1,000 12,550 On August 26, 2020, the Company issued an aggregate of 117,200 117,200 1.00 On September 1, 2020, the Company issued an aggregate of 38,219 38,219 1.00 On September 2, 2020, the Company issued an aggregate of 4,351 4,351 1.00 On September 8, 2020, the Company issued an aggregate of 33,600 33,600 1.00 On September 10, 2020, the Company issued an aggregate of 114,457 114,457 1.00 On September 11, 2020, the Company issued an aggregate of 15,000 15,000 1.00 On September 14, 2020, the Company issued an aggregate of 66,294 66,294 1.00 On September 15, 2020, the Company issued an aggregate of 13,529 13,529 1.00 On September 16, 2020, the Company issued an aggregate of 30,275 30,275 1.00 On September 17, 2020, the Company issued an aggregate of 33,197 33,197 1.00 On September 21, 2020, the Company issued an aggregate of 5,780 5,780 1.00 On September 22, 2020, the Company issued an aggregate of 55,005 55,005 1.00 On September 30, 2020, the Company issued an aggregate of 43,240 43,240 1.00 On November 3, 2020, the Company issued an aggregate of 6,061 6,061 1.00 On November 5, 2020, the Company issued an aggregate of 25,848 25,848 1.00 On November 6, 2020, the Company issued an aggregate of 11,340 11,340 1.00 On November 11, 2020, the Company issued an aggregate of 20,000 20,000 1.00 On November 13, 2020, the Company issued an aggregate of 38,894 38,894 1.00 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) Stock Options Options Issued Outside of Equity Incentive Plan On August 24, 2021, the Company issued to Douglas Ellenoff, Chief Business Development Strategist, 300,000 options which are fully vested, to purchase its common stock. The Company will issue an additional 150,000 options per year for the next three years which will be fully vested at the end of each year, as long as Mr. Ellenoff remains employed by the Company. During the next three years, Mr. Ellenoff will be eligible to receive an additional 250,000 per year on each of the first three anniversaries of the commencement of his employment if during each such year Mr. Ellenoff introduces the Company to twelve (12) or more potential Business Transactions (as defined in the Ellenoff Agreement and which transactions need not be consummated); provided that the Company’s Chief Executive Officer may, in his sole discretion, waive the vesting requirement in any given year. Such options have an exercise price of $5.35 per share and will terminate 5 years after they vest Also on August 24, 2021, the Company granted 25,000 5.35 The 325,000 3.24 1,053,064 5.37 75.25 5 0.28 On October 8, 2021, the Company granted 25,000 5.35 five years The 25,000 2.90 72,350 4.75 80 5 years 0.28 2018 Incentive Plan On June 14, 2018, our Board of Directors approved the 2018 Incentive Plan (the “2018 Plan”). The purpose of the 2018 Plan is to provide a means for the Company to continue to attract, motivate and retain management, key employees, consultants and other independent contractors, and to provide these individuals with greater incentive for their service to the Company by linking their interests in the Company’s success with those of the Company and its shareholders. An award may also be granted to any consultant, agent, advisor or independent contractor for bona fide services rendered to the Company or any Related Company (as defined in the 2018 Plan) that; are not in connection with the offer and sale of the Company’s securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market for the Company’s securities. The 2018 Plan is administered by the Board its Compensation Committee and may grant Options designated as Incentive Stock Options or Nonqualified Stock Options. The 2018 Plan provides that up to a maximum of 13,333 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) Amended and Restated 2020 Equity Incentive Plan On August 21, 2020, the Company’s Board of Directors approved and adopted the Company’s 2020 Equity Incentive Plan (the “2020 Plan”) in order to provide a means for the Company to continue to attract, motivate and retain management, key employees, directors and consultants. On December 31, 2020, the Company’s Board of Directors approved and adopted an amendment that increased the number of shares available for issuance under the 2020 Plan from 450,000 800,000 1-for-5 reverse split The A&R 2020 Plan provides for discretionary awards of, among others, stock options, stock awards, stock unit awards and stock appreciation rights to participants. Each award made under the A&R 2020 Plan will be evidenced by a written award agreement specifying the terms and conditions of the award as determined by the Committee in its sole discretion, consistent with the terms of the A&R 2020 Plan. All employees, directors, and consultants of the Company and its subsidiaries are eligible to receive awards under the A&R 2020 Plan. The A&R 2020 Plan is administered by the “Committee” which is defined in the A&R 2020 Plan as the Compensation Committee of the Board or such other committee as may be designated by the Board from time to time to administer the Plan, or, if no such committee has been designated at the time of any grants, it shall mean the Board. The number of shares of common stock that may be issued under the A&R 2020 Plan is 800,000 The maximum number of shares subject to Awards granted under the A&R 2020 Plan or otherwise during any one calendar year to any Director for service on the Board (other than to Mr. Phipps and the Company’s CEO and President, if serving on the Board, to whom no annual limit is applicable), taken together with any cash fees paid by the Company to such Director during such calendar year for service on the Board, will not exceed $ 100,000 The Committee may amend any award agreement at any time, provided that no amendment may adversely affect the right of any participant under any agreement in any material way without the written consent of the participant, unless such amendment is required by applicable law, regulation or stock exchange rule. The Board may terminate, suspend or amend the A&R 2020 Plan, in whole or in part, from time to time, without the approval of the shareholders, unless such approval is required by applicable law, regulation or stock exchange rule, and provided that no amendment may adversely affect the right of any participant under any outstanding award in any material way without the written consent of the participant, unless such amendment is required by applicable law, regulation or rule of any stock exchange on which the shares are listed. Notwithstanding the foregoing, neither the A&R 2020 Plan nor any outstanding award agreement can be amended in a way that results in the repricing of a stock option. Repricing is broadly defined to include reducing the exercise price of a stock option or cancelling a stock option in exchange for cash, other stock options with a lower exercise price or other stock awards. No awards may be granted under the A&R 2020 Plan on or after the tenth anniversary of the effective date of the A&R 2020 Plan. The Company uses the Black-Scholes Model to calculate the fair value of its options. The valuation result generated by this pricing model is necessarily driven by the value of the underlying common stock incorporated into the model. Management determined the expected volatility was 462.15 0.68 0.93 830,900 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) 2021 Equity Incentive Plan The Company’s Board of Directors approved and adopted the 2021 Incentive Award Plan (“2021 Plan”), subject to stockholder approval, on August 10, 2021. The 2021 Plan was approved by the Company’s stockholders on December 16, 2021, at the Company’s 2021 Annual Meeting of Stockholders. The purpose of the 2021 Plan is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company and its subsidiaries by providing these individuals with equity ownership opportunities. The number of shares initially available for issuance under awards granted pursuant to the 2021 Plan is 768,819 12 All employees, directors, and consultants of the Company and its subsidiaries are eligible to receive awards under the 2021 Plan. As of October 22, 2021, eighteen individuals are eligible to receive awards under the 2021 Plan. The 2021 Plan is generally administered by the Board, which may delegate its duties and responsibilities to committees of Board and or officers of the Company (referred to collectively as the “plan administrator”). The plan administrator will have the authority to make all determinations and interpretations under, prescribe all forms for use with, and adopt rules for the administration of, the 2021 Plan, subject to its express terms and conditions. The plan administrator will also set the terms and conditions of all awards under the 2021 Plan, including any vesting and vesting acceleration conditions. The plan administrator may also institute and determine the terms and conditions of an “exchange program,” which could provide for the surrender or cancellation, transfer, or reduction or increase of exercise price, of outstanding awards, subject to the limitations provided for in the Incentive Award Plan. The 2021 Plan provides for the grant of stock options, including incentive stock options, or ISOs, and nonqualified stock options, or NSOs; restricted stock; dividend equivalents; restricted stock units, or RSUs; stock appreciation rights, or SARs; and other stock or cash-based awards. All awards under the 2021 Plan will be set forth in award agreements, which will detail the terms and conditions of the awards, including any applicable vesting and payment terms and post-termination exercise limitations. Other Stock or Cash Based Awards may be granted to participants, including awards entitling participants to receive shares to be delivered in the future and including annual or other periodic or long-term cash bonus awards (whether based on specified performance criteria or otherwise), in each case subject to any conditions and limitations in the 2021 Plan. The plan administrator will determine the terms and conditions of other stock or cash-based awards. Performance awards include any of the foregoing awards that are granted subject to vesting and/or payment based on the attainment of specified performance goals or other criteria the plan administrator may determine, which may or may not be objectively determinable. Performance criteria upon which performance goals are established by the plan administrator. In connection with certain transactions and events affecting the Company’s Common Stock, including a change in control (as defined in the 2021 Plan), or change in any applicable laws or accounting principles, the plan administrator has broad discretion to take action under the 2021 Plan to prevent the dilution or enlargement of intended benefits, facilitate such transaction or event, or give effect to such change in applicable laws or accounting principles. This includes cancelling awards in exchange for either an amount in cash or other property with a value equal to the amount that would have been obtained upon exercise or settlement of the vested portion of such award or realization of the participant’s rights under the vested portion of such award, accelerating the vesting of awards, providing for the assumption or substitution of awards by a successor entity, adjusting the number and type of shares available, replacing awards with other rights or property and/or terminating awards under the 2021 Plan. On December 16, 2021, the Company granted 100,000 3.81 ten-year December 16, 2031 75,000 10,000 15,000 The vested portion of the options granted, 50,000 3.04 151,940 3.81 80 10 0.28 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) For the years ended December 31, 2021 and 2020, the Company recorded total stock-based compensation of $ 3,758,424 904,900 Stock options outstanding at December 31, 2021 and 2020, as disclosed in the below table, have approximately ($ 270,837 3,012,851 A summary of the status of the Company’s outstanding stock options and changes during the years ended December 31, 2021 and 2020, is as follows: SCHEDULE OF OUTSTANDING STOCK OPTIONS ACTIVITIES Number of Weighted Weighted Balance at January 1, 2020 7,809 $ 87.45 5.16 Granted 698,400 $ 1.20 9.92 Exercised (106,200 ) $ 1.00 9.64 Forfeited - $ - - Cancelled - $ - - Balance outstanding at December 31, 2020 600,009 $ 2.35 9.91 Options exercisable at December 31, 2020 600,009 $ 2.35 9.91 Weighted average fair value of options granted during the period $ 1.20 9.92 Balance at January 1, 2021 600,009 $ 2.35 9.91 Granted 400,000 $ 2.22 5.32 Exercised (19,200 ) $ - - Forfeited (917 ) $ - - Cancelled (50,000 ) $ - - Balance outstanding at December 31, 2021 929,892 $ 3.53 5.32 Options exercisable at December 31, 2021 929,892 $ 3.53 5.32 Weighted average fair value of options granted during the period $ 2.22 5.32 Restricted Stock Awards On February 23, 2021, the Company issued an aggregate of 1,000 14,200 On May 28, 2021, the Company awarded 600,000 shares of restricted common stock Chief Executive Officer, This equity award was made outside of a shareholder approved stock or option plan pursuant to the Nasdaq “inducement grant” exception (Nasdaq Listing Rule 5635(c)(4)). On August 24, 2021, in connection with Paul R. Thomson employment as Executive Vice President, and currently Chief Financial Officer, and as a material inducement to enter into the Thomson Agreement, Mr. Thomson received a restricted stock grant of 25,000 10,000 15,000 5,000 Also on August 24, 2021, under the terms of the Ellenoff Agreement, Douglas Ellenoff, Chief Business Development Strategist, will receive, in lieu of cash compensation: (i) a restricted stock award of 100,000 40,000 60,000 20,000 NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) NOTE 12 - STOCKHOLDERS’ EQUITY (CONTINUED) On October 8, 2021, in connection with Andrew Cohen employment as Senior Vice President of Operations, and as a material inducement to enter into the Cohen Agreement, Mr. Cohen received a restricted stock grant of 25,000 10,000 15,000 5,000 On December 16, 2021, the following awards of unregistered restricted stock to the Company’s directors and officers became effective; Charles M. Fernandez, Executive Chairman and Chief Executive Officer- (1) Award of 101,000 275,000 David Phipps, Director and President of Orbsat; Chief Executive Officer of Global Operations - Award of 275,000 Kendall Carpenter, Director - Award of 20,000 Louis Cusimano, Director - Award of 20,000 Hector Delgado, Director - Award of 20,000 John Miller, Director - Award of 20,000 Paul R. Thomson, Executive Vice President and Chief Financial Officer – Award of 10,000 Theresa Carlise, Chief Accounting Officer, Treasurer and Secretary - Award of 15,000 For the year ended December 31, 2021, the Company recorded total stock-based compensation for the awards and options granted of $ 3,758,424 . For the year ended December 31, 2020, the Company recorded stock-based compensation of $ 904,900 . NEXTPLAT CORP AND SUBSIDIARIES FKA: ORBSAT CORP NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) |